The latest Asthma management guidelines 2025 from the VA and DOD offer a simplified approach to chronic respiratory care. Consequently, this synopsis focuses on practical strategies for clinicians to improve symptom control. Furthermore, primary care providers can now utilize more streamlined pharmacological pathways for their patients.
New Standards for Pharmacological Management
The 2025 update strongly emphasizes inhaled corticosteroids (ICS) as the core foundation of asthma therapy. Additionally, the guideline suggests using a combination of ICS and rapid-onset long-acting β-agonists for relief and control. This approach, known as SMART therapy, replaces traditional short-acting reliever protocols. Moreover, clinicians should consider step-up therapy by increasing the ICS dose or adding long-acting anticholinergic agents.
Addressing Comorbidities and Environment
In addition to medication, the guideline highlights the importance of managing comorbid conditions effectively. Specifically, the work group supports treating symptomatic gastroesophageal reflux disease and addressing patient obesity. Losing more than 5% of body weight significantly improves asthma outcomes according to recent clinical evidence. However, the group suggests against using indoor air filtration devices due to a lack of clinical benefit. Therefore, focus should remain on evidence-based lifestyle interventions and correct inhaler use.
Implementing Asthma Management Guidelines 2025 in Practice
Primary care teams must also identify specific decision points for specialist referral. Furthermore, complex cases still require subspecialist intervention to prevent long-term lung damage. By adhering to these algorithms, doctors can ensure patients receive high-quality, standardized care. Additionally, moving away from symptom-driven therapy aligns with current global respiratory trends.
Frequently Asked Questions
Q1: What is the preferred reliever therapy according to the 2025 guidelines?
The guidelines suggest using a combination of an inhaled corticosteroid and a rapid-onset long-acting beta-agonist as both the reliever and the maintenance treatment.
Q2: Should clinicians recommend indoor air filters for asthma patients?
No, the 2025 VA/DOD guideline suggests against the routine use of indoor air filtration devices as they do not provide a meaningful clinical benefit for asthma control.
Q3: How does weight loss impact asthma management?
Weight loss of more than 5% is supported for patients with obesity, as it has been shown to improve asthma control and overall respiratory health.
References
- Sharafkhaneh A et al. A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Asthma. Ann Intern Med. 2026 Feb 17. doi: 10.7326/ANNALS-25-03080. PMID: 41698207.
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2025.
- U.S. Department of Veterans Affairs. VA/DOD Clinical Practice Guideline for the Primary Care Management of Asthma, 2025.